1. Home
  2. BCYC vs CCBG Comparison

BCYC vs CCBG Comparison

Compare BCYC & CCBG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BCYC
  • CCBG
  • Stock Information
  • Founded
  • BCYC 2009
  • CCBG 1895
  • Country
  • BCYC United Kingdom
  • CCBG United States
  • Employees
  • BCYC N/A
  • CCBG N/A
  • Industry
  • BCYC Biotechnology: Pharmaceutical Preparations
  • CCBG Major Banks
  • Sector
  • BCYC Health Care
  • CCBG Finance
  • Exchange
  • BCYC Nasdaq
  • CCBG Nasdaq
  • Market Cap
  • BCYC 566.5M
  • CCBG 580.7M
  • IPO Year
  • BCYC 2019
  • CCBG N/A
  • Fundamental
  • Price
  • BCYC $8.22
  • CCBG $38.01
  • Analyst Decision
  • BCYC Buy
  • CCBG Buy
  • Analyst Count
  • BCYC 10
  • CCBG 2
  • Target Price
  • BCYC $25.00
  • CCBG $39.00
  • AVG Volume (30 Days)
  • BCYC 333.0K
  • CCBG 23.6K
  • Earning Date
  • BCYC 05-01-2025
  • CCBG 07-22-2025
  • Dividend Yield
  • BCYC N/A
  • CCBG 2.37%
  • EPS Growth
  • BCYC N/A
  • CCBG 11.98
  • EPS
  • BCYC N/A
  • CCBG 3.37
  • Revenue
  • BCYC $25,722,000.00
  • CCBG $236,037,000.00
  • Revenue This Year
  • BCYC N/A
  • CCBG $10.45
  • Revenue Next Year
  • BCYC $1.83
  • CCBG $3.50
  • P/E Ratio
  • BCYC N/A
  • CCBG $11.20
  • Revenue Growth
  • BCYC N/A
  • CCBG 6.63
  • 52 Week Low
  • BCYC $6.10
  • CCBG $25.45
  • 52 Week High
  • BCYC $28.67
  • CCBG $40.86
  • Technical
  • Relative Strength Index (RSI)
  • BCYC 49.16
  • CCBG 55.87
  • Support Level
  • BCYC $8.00
  • CCBG $36.97
  • Resistance Level
  • BCYC $8.73
  • CCBG $38.72
  • Average True Range (ATR)
  • BCYC 0.48
  • CCBG 0.85
  • MACD
  • BCYC 0.02
  • CCBG -0.09
  • Stochastic Oscillator
  • BCYC 33.33
  • CCBG 56.49

About BCYC Bicycle Therapeutics plc

Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.

About CCBG Capital City Bank Group

Capital City Bank Group Inc is a United States-based group engaged in Banking services, Trust and asset management services, and Brokerage services. The company operates in one segment with two principal services: Banking Services and Wealth Management Services. It offers retail and commercial banking business in the form of traditional deposit and credit services, asset management, trust, mortgage banking, merchant services, bank cards, data processing, and securities brokerage services among others through its banking offices in Florida, Georgia, and Alabama.

Share on Social Networks: